Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Idronoxil Combined With Radiation Treatment in Men With Metastatic Prostate Cancer

NCT03041285 is registered in ClinicalTrials.gov with Royal North Shore Hospital as lead sponsor.

NCT NCT03041285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03041285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Idronoxil Combined With Radiation Treatment in Men With Metastatic Prostate Cancer
Lead sponsor
Royal North Shore Hospital
Phase
Phase 1
Overall status
Terminated
Start date
August 31, 2017
Completion date
September 17, 2019
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castrate- resistant prostate cancer